Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis. [electronic resource]
Producer: 20180611ISSN:- 1941-7705
- Angiotensin Receptor Antagonists -- adverse effects
- Antihypertensive Agents -- adverse effects
- Benzimidazoles -- adverse effects
- Biphenyl Compounds
- Databases, Factual
- Drug Costs
- Drug Substitution -- adverse effects
- Drugs, Generic -- adverse effects
- Emergency Service, Hospital
- Humans
- Hypertension -- diagnosis
- Losartan -- adverse effects
- Patient Admission
- Patient Safety
- Population Surveillance
- Quebec -- epidemiology
- Referral and Consultation
- Retrospective Studies
- Risk Factors
- Tetrazoles -- adverse effects
- Therapeutic Equivalency
- Time Factors
- Treatment Outcome
- Valsartan -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.